BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 156427)

  • 1. Prediction of kidney transplant survival by the direct macrophage-inhibition test.
    Schweizer RT; Olson EC; Hosey DA; Bartus SA
    Transplant Proc; 1979 Mar; 11(1):411-4. PubMed ID: 156427
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinico-immunologic problems in kidney transplantation].
    Lanzer G
    Wien Med Wochenschr; 1981; 131(6):139-43. PubMed ID: 6455015
    [No Abstract]   [Full Text] [Related]  

  • 3. Leukocyte migration inhibitory factor (LIF) as an indicator of presensitization and allograft survival.
    Cochrum KC; Haynes DM; Salvatierra O; Feduska NJ; Vincenti F; Van Speybroeck J
    Transplant Proc; 1978 Jun; 10(2):455-8. PubMed ID: 150081
    [No Abstract]   [Full Text] [Related]  

  • 4. Tissue typing in renal transplantation: the impact of cyclosporine.
    Benvenisty AI; Cohen DJ; Hardy MA
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):19-28. PubMed ID: 2938321
    [No Abstract]   [Full Text] [Related]  

  • 5. Leukocyte migration inhibitory factor (LIF) as an indicator of mixed lymphocyte culture (MLC) reactivity.
    Cochrum KC; Salvatierra O; Cullen BL; Perkins HA; Hanes DM; Fudenberg HH
    Transplant Proc; 1977 Mar; 9(1):97-101. PubMed ID: 141146
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation of mixed lymphocyte culture reactivity and graft survival in one haplotype-matched recipients.
    Garovoy MR; Person A; Carpenter CB
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():208-11. PubMed ID: 158753
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of antiglobulin microcytotoxicity test and mixed leukocyte culture to evaluate prognosis in renal transplant recipients.
    Farrow SS; Rossen RD; Suki WN; Hersh EM
    Proc Clin Dial Transplant Forum; 1973; 3():74-6. PubMed ID: 4283133
    [No Abstract]   [Full Text] [Related]  

  • 8. [HLA-compatibility testing in kidney transplantation--past, present and future].
    van Rood JJ; Persijn GG; van Leeuwen A; Goulmy E; Lansbergen Q; Cohen B
    Chirurg; 1980 May; 51(5):257-62. PubMed ID: 6447582
    [No Abstract]   [Full Text] [Related]  

  • 9. The relationship of renal transplant survival to cellular and humoral responsiveness.
    MacSween JM; Cohen AD; Eastwood SL; Rajaraman K
    Transplant Proc; 1987 Aug; 19(4):3419-21. PubMed ID: 3303508
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful cadaveric and living related donor renal transplantation in patients with historical positive and pretransplant negative crossmatch.
    Baquero A; Om A; McAlack R; Raja R; Bannett AD
    Transplant Proc; 1987 Apr; 19(2):2946-8. PubMed ID: 3551238
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal transplantation between 33 HL-A-identical siblings.
    Descamps B; Hinglais N; Crosnier J
    Transplant Proc; 1973 Mar; 5(1):231-6. PubMed ID: 4266652
    [No Abstract]   [Full Text] [Related]  

  • 12. Significance of HLA-DR matching and of B cell crossmatch tests in vitro and in cadaver renal transplantation.
    Albrechtsen D; Arnesen E; Solheim BG; Thorsby E
    Transplant Proc; 1979 Mar; 11(1):743-7. PubMed ID: 156432
    [No Abstract]   [Full Text] [Related]  

  • 13. MLC incompatibility index for donor--recipient matching.
    Uehling DT; Hussey JL; Belzer FO; Kan C; Bach FH
    Transplant Proc; 1977 Mar; 9(1):103-5. PubMed ID: 141120
    [No Abstract]   [Full Text] [Related]  

  • 14. DL-A LD matching: its prognostic value for kidney allograft survival.
    Bach ML; Bach FH; Rasmus W; Burkholder PM; Dufek J; Kahn D
    Transplant Proc; 1975 Sep; 7(3):423-5. PubMed ID: 125946
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal transplantation between histocompatible donor-recipient pairs.
    Seigler HF; Stickel DL; Gunnells JC; McCoy R; Ward FE; Anderson EE; Amos DB
    Transplant Proc; 1972 Dec; 4(4):439-46. PubMed ID: 4264867
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of cell-mediated lympholysis and mixed lymphocyte culture in the immunologic evaluation for renal transplantation.
    Harmon WE; Parkman R; Lavin PT; Grupe WE; Ingelfinger JR; Yunis EJ; Levey RH
    J Immunol; 1982 Oct; 129(4):1573-7. PubMed ID: 6213715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometry crossmatch before kidney transplantation in contemporary practice: target cell utilization, results patterns, and associated long-term graft survival.
    Lentine KL; Graff RJ; Xiao H; Modanlou KA; Salvalaggio PR; Brennan DC; Pinsky BW; Burroughs TE; Schnitzler MA
    Clin Transpl; 2008; ():253-66. PubMed ID: 19708460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cellular immunity to donor antigens after kidney transplants in humans].
    Friemel H; Brock J; Jenssen HL; Köhler H; Solga U; May G; Philipp H
    Z Exp Chir; 1975; 8(6):350-5. PubMed ID: 802852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretransplant blood transfusions and kidney allograft survival. A clinical and immunological study.
    Fehrman I
    Scand J Urol Nephrol Suppl; 1981; 65():1-46. PubMed ID: 6217543
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship of mixed lymphocyte culture (MLC) response and kidney graft survival in living related donor transplants.
    Lazda VA; Jonasson O; Mozes MF
    Transplant Proc; 1981 Mar; 13(1 Pt 2):949-52. PubMed ID: 6455829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.